Meyka AI API is live for developers.Start building.
Advertisement
Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc. (KRTX) Stock Overview

Explore Karuna Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

KRTX●NASDAQ
HealthcareBiotechnology
$329.83
$0.09(0.03%)
U.S. Market opens in 56h 2m
Advertisement

Karuna Therapeutics, Inc. (KRTX)

Meyka AI Score

Z

Key Financials

Market Cap12.6B
P/E Ratio-28.11
EPS (TTM)$-11.74
ROE-0.36%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$407.12

KRTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Karuna Therapeutics, Inc. (KRTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $407.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.11 and a market capitalization of 12.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.03%
3-Month Change
4.13%
6-Month Change
92.87%
Year-to-Date (YTD) Change
4.79%
1-Year Change
80.59%
3-Year Change
185.72%
5-Year Change
1547.50%
All-Time (Max) Change
1547.50%

Contact Information

https://www.karunatx.com
857 449 2244
99 High Street, Boston, MA, 02110

Company Facts

3,390 Employees
IPO DateJun 28, 2019
CountryUS

Frequently Asked Questions